Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 8/20 | 0.45 |
| ▸ | TP53 | P04637 | 4/20 | 0.45 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13545880 | 0.92 | SMN1; SMN2 (0.60) | SMN1; SMN2ALDH1A1MAPTTP53THRB | |
| SCHEMBL13545868 | 0.88 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1MAPTTP53THRB | |
| SCHEMBL13545881 | 0.87 | ALDH1A1 (0.61) | SMN1; SMN2ALDH1A1MAPTTP53THRB | |
| SCHEMBL13545882 | 0.86 | ALDH1A1 (0.59) | SMN1; SMN2ALDH1A1MAPTTP53THRB | |
| SCHEMBL13545877 | 0.79 | ALDH1A1 (0.65) | SMN1; SMN2ALDH1A1MAPTTP53THRB | |
| SCHEMBL13545864 | 0.78 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPTTP53THRB | |
| SCHEMBL13545876 | 0.73 | MAPT (0.53) | SMN1; SMN2ALDH1A1MAPTTP53THRB | |
| SCHEMBL13545780 | 0.73 | SMN1; SMN2 (1.00) | SMN1; SMN2ALDH1A1MAPTTP53TDP1 | |
| SCHEMBL13545866 | 0.73 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1MAPTTP53TDP1 | |
| SCHEMBL13545860 | 0.71 | SMN1; SMN2 (0.53) | SMN1; SMN2ALDH1A1MAPTTP53THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100022530-A1 | TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN | MERCK PATENT GMBH (DE) | 2010-01-28 | — | — | US | disclosed |
| US-20100022530-A1 | TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN | MERCK PATENT GMBH (DE) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022530-A1 | TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN | CCNB3, TUBB3, CCNB1 | SMN1; SMN2 153/4885ALDH1A1 2977/4885MAPT 807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.